Catalyst Wire Dossier Catalyst Wire Dossier

T-regulatory cell and CD3-depleted double umbilical cord blood transplantation

· Masonic Cancer Center, University of Minnesota
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-regulatory cell and CD3-depleted double umbilical cord blood transplantation, covering 2017-12-02 to 2017-12-02. Get the full timeline:

Most recent: Clinical Trial Update: T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies [Phase 1, Phase 2]

See pricing